Viral Vectors and Plasmid DNA Manufacturing Market Insights Video
According to Cognitive Market Research, the global Viral Vectors and Plasmid DNA Manufacturing market size is USD 936.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 11.50% from 2024 to 2031.
North America held the major market share for more than 40.0% of the global revenue with a market size of USD 374.60 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 280.95 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 215.40 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.6% from 2024 to 2031.
Latin America had a market share of more than of the global revenue with a market size of USD 46.83 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.0% from 2024 to 2031.
Middle East and Africa had a market share of around 2.0% of the global revenue and was estimated at a market size of USD 18.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.3% from 2024 to 2031.
The Gene Therapy held the highest Viral Vectors and Plasmid DNA Manufacturing market revenue share in 2024.
